Biological Features Implies Potential Use of Autologous Adipose-Derived Stem/Progenitor Cells in Wound Repair and Regenerations for the Patients with Lipodystrophy

The study explored the potential use of autologous adipose-derived stem/progenitor cells (ADSCs) for regenerative therapy in patients with lipodystrophy, particularly those with HIV undergoing HAART treatment. Despite the limited number of cases, the research found that ADSCs from both HIV-infected and uninfected patients exhibited similar growth properties and adipogenic differentiation capabilities in vitro. This suggested that ADSCs from lipodystrophy patients retained sufficient physiological and biological activity for adipose tissue reconstitution, indicating their potential use in autologous ADSC-based regenerative therapies to improve quality of life by addressing soft tissue loss.